Q2 2021 13F Holders as of 6/30/2021
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
104M
-
Number of holders
-
44
-
Total 13F shares, excl. options
-
6.52M
-
Shares change
-
-2.25M
-
Total reported value, excl. options
-
$21.4M
-
Value change
-
-$7.66M
-
Number of buys
-
17
-
Number of sells
-
-37
-
Price
-
$3.29
Significant Holders of VOLITIONRX LTD - Common Stock, par value $0.001 per share (VNRX) as of Q2 2021
66 filings reported holding VNRX - VOLITIONRX LTD - Common Stock, par value $0.001 per share as of Q2 2021.
VOLITIONRX LTD - Common Stock, par value $0.001 per share (VNRX) has 44 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 6.52M shares
of 104M outstanding shares and own 6.29% of the company stock.
Largest 10 shareholders include Lagoda Investment Management, L.P. (2.73M shares), MORGAN STANLEY (609K shares), BlackRock Inc. (552K shares), VANGUARD GROUP INC (499K shares), BRIDGEWAY CAPITAL MANAGEMENT, LLC (303K shares), MILLENNIUM MANAGEMENT LLC (275K shares), GEODE CAPITAL MANAGEMENT, LLC (262K shares), RENAISSANCE TECHNOLOGIES LLC (247K shares), Ergoteles LLC (135K shares), and STATE STREET CORP (105K shares).
This table shows the top 44 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.